Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Inclusion Criteria: * Patients aged 7 years and older must have provided written assent accompanied by written informed consent from patient's representative * Clinical diagnosis of stable plaque psoriasis with involvement of ≥ 10% body surface area (excluding face and scalp) * Physicians Global Assessment score of 3 or 4 at baseline Exclusion Criteria: * Has other dermatological conditions that may interfere with clinical assessments * Allergy or sensitivity to corticosteroids or any drug hypersensitivity or intolerance that would compromise patient safety or study results * History of an adverse reaction to Cortrosyn™ or similar test reagents * Chronic infectious disease, system or organ disorder or other medical condition that would place patient at undue risk by study participation